Science Explorer Back to mapMap
Discussion
Institution · ARMGO Pharma (United States)

Most cited papers from ARMGO Pharma (United States)

ARMGO Pharma (United States)

What are the most cited papers from ARMGO Pharma (United States)?

The most cited paper from ARMGO Pharma (United States) is "Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl–positive human acute leukemia cells" (Ramadevi Nimmanapalli, Lianne Fuino, Corinne Stobaugh et al., 2003), with 220 citations. Next come "Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge" (177) and "Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge" (126).

Showing 17 of 17 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl–positive human acute leukemia cells Ramadevi Nimmanapalli, Lianne Fuino, Corinne Stobaugh et al. · Blood Open access 2 Apr 2003 220
2 Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge Jose M. Galarza, Theresa E. Latham, Albert Cupo · Viral Immunology Jun 2005 177
3 Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge Jose M. Galarza, Theresa E. Latham, Albert Cupo · Viral Immunology Mar 2005 126
4 Mast Cell Activation Syndrome: A Primer for the Gastroenterologist Leonard B. Weinstock, Laura Pace, Ali Ranjideh Rezaie et al. · Digestive Diseases and Sciences 23 Apr 2020 61
5 Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms Craig D. Shimasaki, Richard E. Frye, Rosario Rich Trifiletti et al. · Journal of Neuroimmunology Open access 14 Dec 2019 60
6 Population PK Analyses of Ubrogepant (MK‐1602), a CGRP Receptor Antagonist: Enriching In‐Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling Chi‐Chung Li, Marissa Fallon Dockendorf, Ken Kowalski et al. · The Journal of Clinical Pharmacology 14 Nov 2017 43
7 Benzo[b]thiophene-based histone deacetylase inhibitors David J. Witter, Sandro Belvedere, Liqiang Chen et al. · Bioorganic & Medicinal Chemistry Letters Open access 7 Jun 2007 39
8 Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial Joshua J. Todd et al. · EClinicalMedicine Open access 25 Jan 2024 29
9 Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models Florian Barthélémy, Richard T. Wang, Christopher P. Hsu et al. · Molecular Therapy — Nucleic Acids Open access 28 Sep 2019 21
10 Identification of Small Molecules That Selectively Inhibit Diacylglycerol Lipase–α Activity Kingsley K. Appiah, Yuval Blat, Barbara Robertson et al. · SLAS DISCOVERY Open access 15 Nov 2013 17
11 Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness Gerhard Josef Molderings, Franz Ludwig Dumoulin, Jürgen Homann et al. · Naunyn-Schmiedeberg s Archives of Pharmacology Open access 6 May 2020 10
12 Mast cell deposition and activation may be a new explanation for epiploic appendagitis Leonard B. Weinstock, Zahid Kaleem, Dale M. Selby et al. · BMJ Case Reports Open access 23 Sep 2018 6
13 Synthesis of 2,3,4,5-Tetrahydrobenzo[1,4]thiazepines via N-Acyliminium Cyclization Shi‐Xian Deng, Zhenzhuang Cheng, Charles L. Ingalls et al. · Organic Process Research & Development 28 Sep 2017 6
14 Opportunities and Challenges in the Discovery of New Central Nervous System Drugs James E. Krause, Bertrand L. Chenard · Annals of the New York Academy of Sciences Nov 2008 4
15 Nikola Tesla: Why was he so much resisted and forgotten? [Retrospectroscope] Max E. Valentinuzzi, Martin Hill Ortiz, Daniel O. Cervantes et al. · IEEE Pulse Nov 2016 3
16 Diabetes treatment by conversion of gut epithelial cells to insulin‐producing cells Domenico Accili, Shivatra Chutima Talchai, Ryotaro Bouchi et al. · Journal of Diabetes Investigation Open access Mar 2024 2
17 Reprint of 'Model of unidirectional block formation leading to reentrant ventricular tachycardia in the infarct border zone of postinfarction canine hearts' Edward J. Ciaccio, James Coromilas, Hiroshi Ashikaga et al. · Computers in Biology and Medicine Open access 28 Aug 2015 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.